Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Advanced Renal Cell Carcinoma Treatment Market to Grow by
The global advanced renal cell carcinoma (RCC) treatment market is projected to grow from $8.73 billion in 2025 to $12.52 billion by 2030, driven by limited treatment options, rising prevalence of RCC, and advancements in targeted therapies and immunotherapies. Key players like Pfizer, Merck & Co., and Bristol-Myers Squibb are prominent in this market, with North America leading regional contributions. The market’s expansion is further supported by investments in immunotherapy research and the adoption of personalized medicine approaches.